What pharmacologic and non‑pharmacologic treatments can be used to reduce libido in women?

Pharmacologic Treatment to Decrease Libido in Women

For women requiring libido reduction, antiandrogens (spironolactone, flutamide, cyproterone acetate) or SSRIs (particularly sertraline or paroxetine) are the primary pharmacologic options, though none are FDA-approved for this specific indication. 1, 2

Pharmacologic Approaches

First-Line: Antiandrogens

• Spironolactone (50-200 mg daily): Blocks peripheral androgen receptors and reduces testosterone production 1, 2
• Flutamide: Potent androgen receptor blocker 1
• Cyproterone acetate: Blocks androgen receptors (not available in US) 2

Mechanism: These agents reduce libido by blocking testosterone's effects at the receptor level or suppressing androgen production. The evidence comes from hyperandrogenism treatment guidelines where these medications are used for opposite purposes, but their side effect profile includes decreased libido 1.

Critical caveat: All antiandrogens are contraindicated in pregnancy and require reliable contraception 1.

Second-Line: SSRIs/SNRIs

• Sertraline (50-100 mg daily) 3
• Paroxetine (12.5-25 mg daily) 3
• Fluoxetine or Citalopram 3

Mechanism: These medications commonly cause decreased libido as a side effect through serotonergic pathways 2, 3, 2. While primarily used for depression and hot flashes in cancer survivors, their libido-reducing effects are well-documented.

Important consideration: Paroxetine is a potent CYP2D6 inhibitor, which matters if the patient is on tamoxifen or other medications metabolized by this pathway 3.

Alternative: Hormonal Suppression

• GnRH agonists with add-back estrogen therapy: Suppresses ovarian androgen production 1
• Medroxyprogesterone: Used specifically to lower libido in behavioral contexts 4
• Combined oral contraceptives: Suppress ovarian androgens through estrogen/progestin effects 1

Non-Pharmacologic Approaches

While the question asks about pharmacologic treatment, comprehensive management should include:

• Psychotherapy/counseling: Cognitive-behavioral approaches can address sexual desire 5, 6
• Addressing underlying conditions: Treat hyperthyroidism, hyperprolactinemia, or other endocrine disorders that may increase libido

Clinical Algorithm

1. Determine the underlying cause: Is elevated libido due to hyperandrogenism, hypersexuality disorder, or other medical condition?

2. If hyperandrogenism present (elevated testosterone, DHEAS):

   • Start spironolactone 50-100 mg daily
   • Monitor potassium levels (risk of hyperkalemia)
   • Titrate up to 200 mg if needed
   • Alternative: flutamide if spironolactone ineffective

3. If normal androgen levels:

   • Consider SSRI therapy (sertraline 50 mg daily as first choice)
   • Titrate based on response and tolerability
   • Expect 4-6 weeks for full effect

4. If severe or refractory:

   • Consider GnRH agonist therapy with endocrinology consultation
   • This creates a hypogonadal state requiring careful management

Critical Warnings

• No FDA approval: None of these medications are FDA-approved for libido reduction in women 1
• Pregnancy risk: Antiandrogens and 5α-reductase inhibitors are absolutely contraindicated in pregnancy due to teratogenic effects 1
• Monitoring required: Regular follow-up for side effects (hyperkalemia with spironolactone, sexual dysfunction with SSRIs, bone health with GnRH agonists)
• Psychiatric evaluation: Rule out hypersexuality as part of bipolar disorder or other psychiatric conditions requiring different management

The evidence base for intentionally reducing female libido is limited, as most research focuses on treating low desire rather than high desire. The recommendations are extrapolated from medications known to cause decreased libido as a side effect in other treatment contexts 1, 2, 3, 2.